Confidently Identify and Manage Histamine Intolerance and MCAS in Your Nutrition Practice!

Histamine intolerance and MCAS affect more of the population than we really know, with middle-aged women getting hit the hardest. Yet many cases remain undiagnosed or misattributed to other conditions. With growing research and clinical recognition, are you equipped with the latest evidence-based approaches?

This comprehensive course provides a systems-based understanding of histamine biology, histamine intolerance (HIT), and Mast Cell Activation Syndrome (MCAS). Participants explore enzymatic pathways, receptor signaling, genetic variability, methylation, detoxification, stress physiology, and gut–immune–brain interactions that drive mast cell dysregulation.

The course differentiates HIT from MCAS and related mast cell disorders while outlining practical diagnostic frameworks and laboratory considerations. Emphasis is placed on layered, individualized interventions—including dietary modification, lifestyle stabilization, targeted nutraceuticals, medical therapies, and advanced mast cell down-regulation strategies.

By integrating foundational science with clinical application, this program equips practitioners to confidently assess and manage complex, multisystem inflammatory presentations.

1. Differentiate Histamine Intolerance from MCAS using symptom patterns and targeted biomarkers (tryptase, DAO, methylation markers) to guide your nutrition care plans.
2. Implement Advanced Dietary Strategies that go beyond basic lists, focusing on what patients CAN eat, including DAO-boosting foods and managing cross-reactivities like oxalates and salicylates.
3. Build Tiered Supplement Protocols appropriate for nutrition practice, confidently using foundational supports (Quercetin, Vitamin C, DAO) and knowing when to collaborate on advanced compounds.
4. Identify and Address Root Causes including gut imbalances, hormonal influences, methylation issues, and environmental triggers.
5. Navigate Complex Comorbidities like POTS, EDS, and biotoxin illness by understanding the neuroimmune-endocrine network.

1. Differentiate histamine intolerance (HIT), Mast Cell Activation Syndrome (MCAS),
   mastocytosis, and secondary mast cell activation using clinical patterns, biochemical mechanisms, and laboratory markers.
2. Explain the core pathways of histamine production, degradation, and mast cell activation, including DAO, HNMT, methylation, FcεRI signaling, and inflammatory mediators.
3. Identify root contributors to mast cell dysregulation, including genetics, gut dysfunction, infections, hormonal imbalance, toxic burden, oxidative stress, and chronic stress physiology.
4. Interpret relevant laboratory and functional markers to support assessment and individualized clinical decision-making.
5. Develop personalized intervention strategies incorporating dietary modification, trigger reduction, mast cell stabilization, nutraceutical support, and circadian/stress regulation.
6. Construct a phased, systems-based treatment plan that prioritizes stabilization, reduces inflammatory burden, and restores long-term immune regulation.